MRI of Inflammatory Bowel Disease

Thomas C. Lauenstein, MD


Appl Radiol. 2008;37(7):19-24. 

In This Article

MRI of Inflammatory Bowel Disease

An appropriate degree of bowel distension is a prerequisite for adequate MRI studies of IBD. Most bowel loops are collapsed in their physiological state. Non-distended bowel segments may result in false-positive and false-negative findings since collapsed segments may mimic bowel wall thickening that can be misinterpreted as IBD. Furthermore, smaller areas of abnormality may be overlooked. Colonic distension can be easily accomplished by the administration of a rectal enema that includes liquid or gasiform contrast agents.[11] However, this issue is more complex for evaluation of the small bowel. Oral contrast agents can be administered via a nasoduodenal tube in a similar manner to that used for conventional enteroclysis. This technique allows for uniformly adequate bowel distension[12,13] (Figure 1). However, this procedure is often perceived as traumatizing by patients because of its invasive character. The oral administration of water without prior GI tract intubation is noninvasive and generally well accepted. However, water is rapidly reabsorbed in the small bowel, and only a moderate degree of bowel distensionis usually achieved.[14,15] Certain additives have been found to slow down intestinal reabsorption of water. Oral solutions containing substances such as mannitol,[16] sorbitol,[17] polyethylene glycol,[14] or ispaghula[18] have been used in this clinical setting. The oral administration of these solutions results in a consistently greater small bowel distension than does the use of water alone.

Fast imaging with steady-state precession of MR enteroclysis. Adequate luminal distension throughout the jejunum and ileum can be achieved by administering contrast media through a duodenal catheter. (Image courtesy of N. Gourtsoyiannis and N. Papanikolaou, University of Heraklion, Greece.)

MRI of the bowel (like abdominal MRI in general) is based on the principles of ultra-fast imaging. In the past, most examinations were performed on 1.5T scanners equipped with strong gradient systems. Only recently, bowel MRI on 3T systems has proved feasible.[19]

A standard preparation for bowel purgation should be performed the day before the MR examination. Approximately 45 minutes prior tothe MR scan, patients are to ingest 1000 to 1500 mL of a water-based solution, eg, one that contains 2.0% mannitol or sorbitol. Volumen (E-Z-EM, Westbury, NY), a commercially available sorbitol-containing product, generally provides good small bowel distension after oral administration.[17,20] The oral contrast should be administered at a steady rate over a 45-minute period. To allow for uniform small bowel filling, additional administration of substances enhancing gastric emptying (eg, metoclopramide) may be useful. Sufficient colonic distensioncan be achieved by an additional rectal enema consisting of 500 mL of warm tap water. Since the use of rigid rectal tubes is inconvenient and uncomfortable, a thin Foley catheter is preferable.

Patients should be examined in the prone position, which has proven advantageous for bowel
MRI.[21] A torso phased-array surface coil should be used for signal reception. It is important to ensure coverage of the entire abdomen and pelvis in the Z-axis, which can usually be obtained by choosing a field of view of 400 to 450 cm. After the collection of a localizer sequence, a 2-dimensional (2D) and/or 3D fastimaging with steady-state precession (FISP) sequence should be collected. Different vendor-specific names for these sequences have beenintroduced, including TrueFISP (Siemens Medical Solutions, Malvern, PA), Balanced Fast Field Echo (Philips Medical Systems, Bothell,WA) and FIESTA (GE Healthcare, Waukesha, WI). One of the main features of this sequence is its relative motion insensitivity, which might be particularly important in patients unable to perform an adequate breath-hold. Fast imaging with steady-state precession data should be collected without fat suppression, because it not only ensures good visualization of the bowel itself but also of the adjacent mesentery and retroperitoneum. Furthermore, single-shot T2-weighted (T2W) sequences with fat saturation should be acquired. This sequence is helpful to depict edema in or adjacent to the bowel wall. Finally, 3D gradient-refocused echo (GRE) T1-weighted (T1W) MRI should be performed in conjunction with the IV administration of paramagnetic contrast. Since these images are most prone to bowel motion artifacts, a spasmolytic agent (eg, glucagon) should be administered intravenously approximately 1 minute before data collection. After acquiring a first precontrast T1W 3D gradient-echo data set, paramagnetic contrast is administered (0.1 to 0.2 mmol/kg gadolinium) and the acquisition is repeated after a delay of 20 seconds (arterial phase), 70 seconds (portal-venous phase), and 120 seconds (delayed phase). Sequence parameters are listed in Table 1 .

All image sets should be transferred to a postprocessing workstation. The contrast-enhanced 3D T1W images are interpreted in a multi-planar reformation (MPR) mode. Thus, the radiologist can scroll through the data set in all 3 orthogonal planes. Numerous different imaging features can be found in patients with IBD. Fast imaging with steady-state precession may be especially helpful to assess bowel wall thickening, mesenteric lymph nodes and peri-intestinal stranding (Figure 2). Furthermore, the presence of fistulae can be easily depicted on these images (Figure3). Gadolinium-enhanced T1W imaging can help to detect IBD independent of its activity state and has a high sensitivity of almost 90% (Figure 4). However, the specificity of T1W imaging is only moderate. It is often difficult to differentiate active versuschronic inflammation. While active disease shows increased contrast enhancement due to increased perfusion and vascularity, chronic inflammatory lesions may also strongly enhance because of fibrotic changes. The latter observation is comparable to findings of late enhancement in infracted myocardial tissue. Hence, the evaluation of disease activity in patients with IBD is a challenging task.

In this patient with ulcerative colitis, fast imaging with steady-state precession reveals a loss of haustral markings and a thickening of the transverse and descending colon (arrows). Further more, increased vascularity adjacent to the affected bowel segment is noted.

As seen in this patient with Crohn's disease, fast imaging with steady-state precession is highly sensitive for the depiction of fistulae (arrow).

Contrast-enhanced (A) axial and (B) coronal T1-weighted MR images reveal increased enhancement of inflamed bowel segments in the ileum and cecum (arrows). However, differentiation between active and chronic disease is not fully possible based on these findings.

Assessment of disease activity is often a key diagnostic factor, as therapeutic options differ for active and chronic IBD. While activeinflammation is treated with systemic cortico steroids or other immunomodulator drugs, interventional or surgical therapeutic options aretypically chosen for chronic disease.[22,23,24] In the past, attempts to classify IBD activity were time-consuming depending on perfusion analyses of the bowel wall. However, T2W imaging with fat suppression may evolve as a reliable marker for the detection of active IBD. Edemain or adjacent to the bowel wall, indicating active inflammation, can easily be appreciated on these images (Figure 5). It is a rapid technique and can be used as a stand-alone tool for determination of IBD activity. Overall, the most accurate diagnostic assessment of IBD is basedon the complementary evaluation of T2W sequences, gadolinium-enhanced T1W sequences and FISP imaging.

Single-shot T2-weighted data with fat suppression is a reliable tool for the depiction of edema in or adjacent to the bowel wall (arrows). This finding correlates well with inflammatory bowel disease activity.

MRI has been successfully applied for the diagnosis and characterization of IBD. Although endoscopy and biopsy are still regarded asstandard procedures for IBD evaluation,[25] recent studies indicate that MRI accurately detects and quantifies extent and activity of IBD.[26,27]

Florie et al[28] evaluated a technique to assess inflammation activity based on different perfusion characteristics in 48 patients with Crohn's disease. AT1W GRE sequence through the abdomen was acquired with an image update every 6 seconds after IV administration of gadolinium. Different parameters (including the slope of enhancement, enhancement ratio, and enhancement time) were correlated with clinically based disease activity indices. These perfusion characteristics were found to be only moderately accurate indicators to determine inflammatory activity. In addition, a rather long postprocessing time for the perfusion analysis was required. Ajaj et al[29] proposed an MRI-based scoring system to measure inflammatory activity. Changes in the bowel wall were documented and quantified according to different criteria,including bowel wall thickness, bowel wall contrast enhancement, and the presence of adjacent lymph nodes. In their study, >90% of bowel segments with IBD changes were correctly diagnosed and categorized as mildly, moderately, or severely inflamed. Although the method showed high accuracy characterizing the activity of IBD, this technique was fairly cumbersome, since several different parameters had to be analyzed. Maccioni et al[30] performed a combined analysis of T2W imaging with fat saturation and contrast enhancement after the IV administration of gadolinium. The T2 signal of the bowel wall and mesentery was found to correlate especially well with the degree of inflammation activity.

There are also some drawbacks inherent to the MRI-based evaluation of IBD. Schreyer et al[31] reported that MRI provided only moderate accuracy for the depiction of subtle inflammatory bowel disease. Mild mucosal inflammation detected by (capsule) endoscopy may be missed by MRI. On the other hand, endoscopic studies may reveal healed mucosal lesions and fail to recognize deeper mural and transmural disease. These observations have been confirmed in a study that compared capsule endoscopy with MRI for Crohn's disease.[32] In this study, 27 patient swith Crohn's disease were studied by MRI and capsule endoscopy. While the latter modality was slightly more sensitive to show mucosal lesions, MRI was superior to determine intramural involvement and extraintestinal complications such as fistulae. Thus, capsule endoscopy and MRI were considered as complimentary tools. However, prior to the performance of capsule endoscopy, an absence of bowel strictures needs to be confirmed. Since this can easily be done by cross-sectional imaging, MRI should be the first-line modality in patients with known or suspected IBD.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: